EVALUATION OF WEIGHT REDUCTION AND METABOLIC PARAMETERS IN HIV COHORT UNDERGOING TREATMENT WITH GLP-1 RECEPTOR AGONISTS AT A LARGE PUBLIC NYC/HHC+ HOSPITAL IN NEW YORK CITY

• Auteur principal: Natalia Nazarenko, MD (Auteur)
• Format: Livre
• Publié: Elsevier, 2024-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Therapeutic Area: Obesity Background: Individuals living with HIV who undergo prolonged combined antiretroviral therapy (cART) may experience weight gain as a potential side effect. Many of these individuals are prescribed GLP-1 receptor agonists (RA), which are recognized for their ability to reduc...